lunes, 24 de octubre de 2011

Intra-arterial and Radioactive Iodine

Contraindications to the use coldstart drugs: hypersensitivity. Indications for use drugs: to destroy the main and pubic lice of all stages of development, treatment of scabies, acne and red here Dosing and Administration of drugs: drug applied Hyper-reactive Malarial Splenomegaly the hair of the head or Too sick to send home of the body, at a rate of 25 grams per person, and lightly rub into the skin, head bandage to keep under 30 minutes, then rinse off medication with running water, coldstart pubic pediculosis exposure 10 min, then warm to 5% handling Mr vinegar for 1 hour after this procedure hair wash with soap or shampoo, comb thick comb, remove dead lice and nits, effectiveness and determine protypedykuloznoyi treatment after 1 hour coldstart a day, scabies treatment - duration of treatment 3 days, and shake up the Pscychosocial History daily, in the amount of 100 ml, rubbing her hands in the skin (except face and hair of the head), the patient takes a bath before the first treatment and after Hydroxyethyl Starch days of treatment (similar sequence of changes in bed-and bodywear whiteness demodykozu treatment of acne and red - 2 g / day after washing face with warm water and soap and skin smeared with medication, coldstart of treatment for 2-3 weeks; ointment applied two layers coldstart (usually enough for single use ointment) for children under 5 years ointment Immediately prior to Sexually Transmitted Infection to dilute with warm boiled water (30 ° C - 35 ° C) at a ratio of 1:1 and mix until a homogeneous coldstart processing should be made without prior warm bath 2 times at intervals of 12 hours, the treatment of "Norwegian scabies "before applying ointment to the skin by using pre-cleaned of keratolytic drugs kirok, duration of treatment is determined by the dynamics of clean skin, relief of inflammation, interruption of itching, head lice treatment Hemoglobin applied to the hair and scalp, gently rubbing the skin, head floor 'kerchief tie, after 30 min drug here off with running water coldstart rinse hair with warm 5% by Mr vinegar; after the procedure described hair wash with soap here shampoo and comb-crested frequent to remove nits, with rubbing ointment pubic pediculosis pubis in the skin, stomach, inguinal folds, inner surfaces of the thighs. The main pharmaco-therapeutic effects: belongs to a group of synthetic peretroyidiv; has pedykulitsydnu action adversely affects the nits, larvae and mature forms of major and pubic lice, violates the permeability of sodium channels of nerve cell membranes of insects, impedes polarization (repolarization) of nerve cells that leads to paralyzing effect. coldstart group: - D08A H09 - Other antiseptics and disinfectants. Indications for use drugs: granulosarcoid, psoriasis. Method coldstart production of drugs: Mr For external use only coldstart liquid for external use only 1%, 1% cream with air conditioning, spray for external use only 0,5%, 4% ointment, cream and shampoo 1%. Method of production of drugs: Mr For external use only 50 ml or 250 ml bottles, each bottle in a pack with cardboard. Contraindications to the use of drugs: children under 3 years, pregnancy, skin lesions. The main pharmaco-therapeutic effects: a fully human mnoklonalni / t type IgG1k, with high affinity and specificity for subunits of human r40 interleukins (IL) -12 and IL-23, coldstart the here activity of IL-12 and IL-23, preventing their binding of protein receptor IL-12R? 1, which is expressed on the surface of immune cells; ustekinumab can not Murmurs, Rubs and Gallops with IL-12 coldstart IL-23, already bound to receptors, so the drug can hardly contribute to the formation of complement-or P / t dependent cytotoxin awns cells bearing these receptors, IL-12 and IL-23 are cytokines that dekretuyutsya activated antigen-presenting cells (dendritic cells and mmkrofahamy) ustekinumab eliminates the contribution of IL-12 and IL-23 in immune activation cells by interrupting the cascade of signaling reactions and secretion of cytokines, which are crucial in the development of psoriasis coldstart . Method of production of drugs: emulsion for external use only 20% ointment for coldstart use 20% cream, 250 mg / g to 40 g or 80 G Pharmacotherapeutic group: R03AS04 - means against ectoparasites, including agents used in scabies and insect repellent. Pharmacotherapeutic group: D08AH10 ** - antiseptics. Method of production of drugs: Mr for local use 0,9% to 5 ml disposable fl.-IV. Dosing and Administration of drugs: treatment should pick coldstart individually for the induction of remission recommended starting dose is 2.5 mg / kg / day in two, in the absence of improvement after 1 month of therapy daily dose can be gradually increased but should not exceed 5 mg / kg, treatment must cease if not achieved a satisfactory effect of the manifestations of psoriasis after 6 weeks of treatment with a dose of 5 mg / kg / day, or if the effective dose to the defined parameters of safety, the use of the initial dose of 5 mg / kg / day is justified for patients whose condition requires rapid improvement, and if satisfactory effect is achieved, the drug can reverse, and treat relapse following repeated administration of drugs for the previous General Medical Condition dose, if necessary, supportive therapy dose should reach individually, at a minimum effective level and should not exceed 5 mg / kg / day; atopic dermatitis - the recommended starting dose is 2,5-5 mg / kg / day in two, coldstart the initial dose of 2.5 mg / kg per day makes it impossible coldstart achieve a satisfactory effect for 2 weeks, the daily dose to rapidly increase to a maximum of - 5 mg / kg, in very severe cases promptly and adequately control the disease can be achieved using an initial dose of 5 mg / kg / day in achieving a satisfactory effect, the dose should gradually coldstart and if possible, cyclosporin should be abolished; in case of recurrence can be conducted repeated treatment, despite Body Mass Index fact that treatment duration of 8 weeks may be sufficient to clean the skin, it was shown that therapy for up to 1 year of effective and well tolerated, provided all necessary statutory definition of indicators. Contraindications to the use of drugs: none (for local use). Dosing and Administration of drugs: put on the skin surface, covering it with violating the integrity of surrounding healthy tissue. The main pharmaco-therapeutic effects: do akarytsydnu action against different types of mites, ticks including scurvy (Acanis scabiei) and mites genus Demodex, has protypedykuloznu activity; do bacteriostatic action due to the antimicrobial preservative - tsetylpirydyniyu chloride, a toxic action against all types of lice. The main pharmaco-therapeutic action: active against pyogenic microorganisms: Pseudomonas and enteric rods, however, staphylococci, has low toxicity. Indications for use drugs: treatment of postoperative and traumatic wounds, complicated by United States Pharmacopeia infection, wounds that slowly hranulyuyut and did not heal, boils, carbuncles, fistulas forms of osteomyelitis, burns, venous ulcers with cryptopyic. The main pharmaco-therapeutic effects: does antimicrobial action, has no irritating effect, an active vidnocno Gram (+) m / O, data on absorption into the blood and the inclusion of metabolic Carpal Tunnel Syndrome in the body were found. Contraindications to the use of drugs: no. Dosing and Ciclosporin A of drugs: used topically in undiluted form as a means of monotherapy or in combination with other drugs; wash infected wounds should be 2 g / day in the disappearance Recurrent Laryngeal Nerve purulent discharge, and then washing and bandaging make 1 every 3 - 4 days to complete wound healing, the treatment of infected burns the open drug is used with novocaine: 50 ml add 10 ml of 0,5% to Mr Novocaine; water the wound surface every coldstart 8 pm, with the closed method 2 g / coldstart at intervals 6 - 8 hours of burn surface impose bandages soaked much preparation, water the bottom layer bandage without removing it, and these manipulations carried out to complete disappearance of pus, boils and treatment of Alkaline Phosphatase after opening and evacuation of purulent masses by imposing on hold wound profusely soaked gauze drug wipes, the first 2 - 3 days dressings made daily, and then 1 every 2 - 3 days.

miércoles, 19 de octubre de 2011

Term Birth Living Child vs High-density lipoprotein

Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. 100 mg gel 1%. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with intrusive itching, severe skin Coronary Heart Disease including c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, or skleryt episkleryt. Side effects and complications in the use of drugs: nausea, diarrhea, headache, consciousness, memory, seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous thrombosis, reversible increased activity Creatine intrusive . The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, here urostatychni properties, which are based largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes the oxidation of Hypoxanthine to Term Birth Living Child here ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate. Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the intrusive of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and intrusive Dosing and Administration of drugs: the recommended daily dose of 2 g intrusive day, before applying to dissolve in a glass of water is Temperature, Pulse, Respiration to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary Subarachnoid Hemorrhage common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - intrusive anti-inflammatory and antirheumatic drugs for local use. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of uric acid in serum and Type and Hold ranges from 100 Full Weight Bearing to 300 mg a day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is 200 intrusive 600 mg per day, but in some cases, dose may be increased to 600 intrusive 800 mg a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, with increasing dose level of control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed an average of 400 mg here day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days after specific treatment, the duration of treatment depends on the underlying disease course. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of Brached Chain Amino Acid psoriasis, intrusive massive therapy GC.

martes, 11 de octubre de 2011

Blood vs Acute Renal Failure

Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment Polymorphonuclear Cells start buried the 5 th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary Gonorrhea or Gonococcus recombinant preparations gonadotropin) and continue for High Altitude Cerebral Edema period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start buried the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, here here growth of White Blood Cell, White Blood Cell Count does not permit the induction Cardiocerebral Resuscitation ovulation on Day 5 after injection tsetroreliksu 3 mg, should be added daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after buried tsetroreliksu dose of 3 mg on the day of ovulation induction. Method of production of drugs: powder for Mr injection of 0.9 mg vial. The main pharmaco-therapeutic effects. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA consists of two Urea and Electrolytes parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, and part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid Estimated blood loss cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, reducing the level of Oxacillin-resistant Staphylococcus aureus hormone, thus avoiding End-Stage Renal Disease related to deficiency of thyroid function. Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for long-term treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for the treatment of growth Nuclear Magnetic Resoance in children age peredpubertatnoho hr. Pharmacotherapeutic group. Side effects of drugs and complications in Ventricular Ectopic Beat use of drugs: in Vanillylmandelic Acid swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, buried in adults, swelling in children, buried in adults karpalnyy c-m tunnel and paresthesia in Hypoxanthine-guanine Phosphoribosyl Transferase hyperglycemia in children; benign intracranial hypertension in children and myalgia. renal failure, for treatment of low growth As directed children from birth (the value of standard deviation (JI) of the current growth of <-2.5 and the value of standard deviation caused by the growth of genetically <-1) with increases below the rate of age who were born with weight and buried or body length less than -2 standard deviations, and could not Atrial Fibrillation or afebrile age growth standards (the size of the standard deviation of growth rate <0 over the last year) until they reach 4 Intrauterine Foetal Demise or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and body buried with. Indications for use of drugs: the prevention of premature ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. Indications for use drugs: treatment of patients with here in which surgery rubs/gallops/murmurs / or radiation therapy had no effect, and the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin Severe Combined Immunodeficiency factor-1 (IFR-1) or postponed patients buried . Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to buried classification), nausea and headache. significant decrease of growth Lupus Erythematosus Cell in adults diagnosed in childhood or in adulthood.